These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 9208276)

  • 1. Heparan sulphate proteoglycans and diabetic nephropathy.
    van der Woude FJ; van Det NF
    Exp Nephrol; 1997; 5(3):180-8. PubMed ID: 9208276
    [No Abstract]   [Full Text] [Related]  

  • 2. Heparan sulfate proteoglycans are lost in patients with diabetic nephropathy.
    Makino H; Ikeda S; Haramoto T; Ota Z
    Nephron; 1992; 61(4):415-21. PubMed ID: 1501738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is microalbuminuria in diabetes due to changes in glomerular heparan sulphate?
    van den Born J; Berden JH
    Nephrol Dial Transplant; 1995; 10(8):1277-9. PubMed ID: 8538909
    [No Abstract]   [Full Text] [Related]  

  • 4. The biology of perlecan: the multifaceted heparan sulphate proteoglycan of basement membranes and pericellular matrices.
    Iozzo RV; Cohen IR; Grässel S; Murdoch AD
    Biochem J; 1994 Sep; 302 ( Pt 3)(Pt 3):625-39. PubMed ID: 7945186
    [No Abstract]   [Full Text] [Related]  

  • 5. [Regulation of cell proliferation by proteoglycans].
    Yanagishita M
    Tanpakushitsu Kakusan Koso; 1998 Dec; 43(16 Suppl):2589-93. PubMed ID: 9883691
    [No Abstract]   [Full Text] [Related]  

  • 6. Ultrastructural changes of extracellular matrices in diabetic nephropathy revealed by high resolution scanning and immunoelectron microscopy.
    Makino H; Yamasaki Y; Haramoto T; Shikata K; Hironaka K; Ota Z; Kanwar YS
    Lab Invest; 1993 Jan; 68(1):45-55. PubMed ID: 8423676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of glomerular extracellular matrix components in human diabetic nephropathy: decrease of heparan sulphate in the glomerular basement membrane.
    Tamsma JT; van den Born J; Bruijn JA; Assmann KJ; Weening JJ; Berden JH; Wieslander J; Schrama E; Hermans J; Veerkamp JH
    Diabetologia; 1994 Mar; 37(3):313-20. PubMed ID: 8174847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparan sulfate proteoglycans function as receptors for fibroblast growth factor-2 activation of extracellular signal-regulated kinases 1 and 2.
    Chua CC; Rahimi N; Forsten-Williams K; Nugent MA
    Circ Res; 2004 Feb; 94(3):316-23. PubMed ID: 14684627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glomerular cell proteoglycans: their possible role in progressive glomerular disease.
    Davies M
    Exp Nephrol; 1995; 3(2):122-6. PubMed ID: 7773631
    [No Abstract]   [Full Text] [Related]  

  • 10. Renal heparan sulfate proteoglycans modulate fibroblast growth factor 2 signaling in experimental chronic transplant dysfunction.
    Katta K; Boersema M; Adepu S; Rienstra H; Celie JWAM; Mencke R; Molema G; van Goor H; Berden JHM; Navis G; Hillebrands JL; van den Born J
    Am J Pathol; 2013 Nov; 183(5):1571-1584. PubMed ID: 24035513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparan sulphate in the binding and activation of basic fibroblast growth factor.
    Gallagher JT; Turnbull JE
    Glycobiology; 1992 Dec; 2(6):523-8. PubMed ID: 1472758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Human heparanase: roles in invasion and metastasis of cancer].
    Gohji K; Katsuoka Y; Okamoto M; Kamidono S; Kitazawa S; Toyoshima M; Dong J; Nakajima M
    Hinyokika Kiyo; 2000 Oct; 46(10):757-62. PubMed ID: 11215206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor-beta 1 increases internalization of basic fibroblast growth factor by smooth muscle cells: implication of cell-surface heparan sulphate proteoglycan endocytosis.
    Berrou E; Quarck R; Fontenay-Roupie M; Lévy-Toledano S; Tobelem G; Bryckaert M
    Biochem J; 1995 Oct; 311 ( Pt 2)(Pt 2):393-9. PubMed ID: 7487873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perlecan: the multidomain heparan sulphate proteoglycan of basement membrane and extracellular matrix.
    Murdoch AD; Iozzo RV
    Virchows Arch A Pathol Anat Histopathol; 1993; 423(4):237-42. PubMed ID: 8236820
    [No Abstract]   [Full Text] [Related]  

  • 15. Heparan sulfate proteoglycans in the human sclerosing and scarring kidney. Changes in heparan sulfate moiety.
    Morita H; David G; Mizutani A; Shinzato T; Habuchi H; Maeda K; Kimata K
    Contrib Nephrol; 1994; 107():174-9. PubMed ID: 8004965
    [No Abstract]   [Full Text] [Related]  

  • 16. A specific structural alteration in the heparan sulphate of human glomerular basement membrane in diabetes.
    Edge AS; Spiro RG
    Diabetologia; 2000 Aug; 43(8):1056-9. PubMed ID: 10990084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The glomerular basement membrane charge-selectivity barrier: an oversimplified concept?
    Goode NP; Shires M; Davison AM
    Nephrol Dial Transplant; 1996 Sep; 11(9):1714-6. PubMed ID: 8918607
    [No Abstract]   [Full Text] [Related]  

  • 18. Heparan sulfate proteoglycans including syndecan-3 modulate BMP activity during limb cartilage differentiation.
    Fisher MC; Li Y; Seghatoleslami MR; Dealy CN; Kosher RA
    Matrix Biol; 2006 Jan; 25(1):27-39. PubMed ID: 16226436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparan sulphate proteoglycans: molecular organisation of membrane--associated species and an approach to polysaccharide sequence analysis.
    Gallagher JT; Turnbull JE; Lyon M
    Adv Exp Med Biol; 1992; 313():49-57. PubMed ID: 1442269
    [No Abstract]   [Full Text] [Related]  

  • 20. Perlecan is responsible for thrombospondin 1 binding on the cell surface of cultured porcine endothelial cells.
    Vischer P; Feitsma K; Schön P; Völker W
    Eur J Cell Biol; 1997 Aug; 73(4):332-43. PubMed ID: 9270876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.